What is the current annual cash & cash equivalents of AZN?

As of today, AZN annual cash & cash equivalents is $5.74B

What is 1-year change in AZN annual cash & cash equivalents?

AZN annual cash & cash equivalents is up +1.54% year-over-year

What is 3-year change in AZN annual cash & cash equivalents?

AZN annual cash & cash equivalents is down -10.37% over the past 3 years

How far is AZN annual cash & cash equivalents from its all-time high?

AZN annual cash & cash equivalents is currently -42.89% below its historical high of $10.05B set on December 31, 2013

How does AZN annual cash & cash equivalents rank versus sector peers?

AZN annual cash & cash equivalents is higher than 97.97% of companies in Healthcare sector

When is AZN next annual earnings release?

As of today, the next annual earnings release for AZN has not been scheduled

What is the current quarterly cash & cash equivalents of AZN?

As of today, AZN quarterly cash & cash equivalents is $4.89B

What is AZN quarterly cash & cash equivalents most recent change?

AZN quarterly cash & cash equivalents was down -36.25% on June 30, 2026

What is 1-year change in AZN quarterly cash & cash equivalents?

AZN quarterly cash & cash equivalents is down -31.16% year-over-year

How far is AZN quarterly cash & cash equivalents from its all-time high?

AZN quarterly cash & cash equivalents is currently -68.69% below its historical high of $15.63B set on June 30, 2021

How does AZN quarterly cash & cash equivalents rank versus sector peers?

AZN quarterly cash & cash equivalents is higher than 97.69% of companies in Healthcare sector

When is AZN next earnings release?

The next earnings release for AZN is on October 30, 2026

AstraZeneca PLC (AZN) Cash & Equivalents History & Chart

Annual Cash & Cash Equivalents

$5.74B$87.00M+1.54%

December 31, 2025

Summary

Current Value: As of today, AZN annual cash & cash equivalents is $5.74B, up +1.54% on December 31, 2025
Historical Performance: AZN annual cash & cash equivalents is down -10.37% over the past 3 years, down -28.17% over the past 5 years
All-Time High Comparison: AZN annual cash & cash equivalents is currently -42.89% below its historical high of $10.05B set on December 31, 2013
3-Year Low Comparison: AZN annual cash & cash equivalents is +1.54% above its 3-year low of $5.65B reached on December 31, 2024
Sector Comparison: AZN annual cash & cash equivalents is higher than 97.97% of companies in Healthcare sector

Cash and Cash Equivalents Chart

beforeafter

SUGGESTED SERIES

Performance

AZN Performance
Metric	Date	Value	1Y	3Y	5Y	15Y
Annual Cash & Cash Equivalents	Dec 31, 25	$5.74B	+1.5%	-10.4%	-28.2%	–
Quarterly Cash & Cash Equivalents	Jun 30, 26	$4.89B	-31.2%	-15.8%	-68.7%	-52.5%
Price	Aug 20, 26	$164.49	+104.4%	+138.8%	+177.0%	+631.9%
Annual Current Assets	Dec 31, 25	$28.72B	+11.2%	+27.1%	+47.0%	+14.1%
Annual Total Liabilities	Dec 31, 25	$65.30B	+3.4%	+9.9%	+27.8%	+99.6%
Annual Working Capital	Dec 31, 25	-$1.89B	+7.1%	+48.8%	-148.2%	-123.1%
Annual Net Income	Dec 31, 25	$10.26B	+45.6%	+211.5%	+226.2%	+26.8%

Cash and Cash Equivalents Highs

AZN Annual Cash & Cash Equivalents Highs Comparison
Period	High	Date	Current
3Y	$6.41B	N/A	-10.4%
5Y	$7.99B	N/A	-28.2%
All	$10.05B	Dec 31, 13	-42.9%

Cash and Cash Equivalents Lows

AZN Annual Cash & Cash Equivalents Lows Comparison
Period	Low	Date	Current
3Y	$5.65B	Dec 31, 24	+1.5%
5Y	$5.65B	Dec 31, 24	+1.5%
All	$613.10M	Dec 31, 90	+836.4%

Cash and Cash Equivalents History

Year	Value	Change
2025	$5.74B	+1.5%
2024	$5.65B	-5.2%
2023	$5.96B	-6.9%
2022	$6.41B	+0.1%
2021	$6.40B	-19.9%
2020	$7.99B	+28.5%
2019	$6.22B	+9.5%
2018	$5.68B	+24.0%
2017	$4.58B	-22.7%
2016	$5.93B	-13.5%
2015	$6.86B	-4.5%
2014	$7.18B	-28.6%
2013	$10.05B	+17.5%

Year	Value	Change
2012	$8.56B	+66.2%
2004	$5.15B	+30.2%
2003	$3.95B	-15.7%
2002	$4.69B	+659.5%
1998	$617.27M	-48.5%
1997	$1.20B	-28.1%
1996	$1.67B	+35.7%
1995	$1.23B	+6.9%
1994	$1.15B	-26.0%
1993	$1.55B	+145.6%
1992	$633.02M	-3.1%
1991	$653.08M	+6.5%
1990	$613.10M	-

FAQ

What is the current annual cash & cash equivalents of AZN?: As of today, AZN annual cash & cash equivalents is $5.74B
What is 1-year change in AZN annual cash & cash equivalents?: AZN annual cash & cash equivalents is up +1.54% year-over-year
What is 3-year change in AZN annual cash & cash equivalents?: AZN annual cash & cash equivalents is down -10.37% over the past 3 years
How far is AZN annual cash & cash equivalents from its all-time high?: AZN annual cash & cash equivalents is currently -42.89% below its historical high of $10.05B set on December 31, 2013
How does AZN annual cash & cash equivalents rank versus sector peers?: AZN annual cash & cash equivalents is higher than 97.97% of companies in Healthcare sector
When is AZN next annual earnings release?: As of today, the next annual earnings release for AZN has not been scheduled

Cash and Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

Quarterly Cash & Cash Equivalents

$4.89B$2.78B-36.25%

June 30, 2026

Summary

Current Value: As of today, AZN quarterly cash & cash equivalents is $4.89B, down -36.25% on June 30, 2026
Historical Performance: AZN quarterly cash & cash equivalents is down -31.16% year-over-year, down -15.81% over the past 3 years
All-Time High Comparison: AZN quarterly cash & cash equivalents is currently -68.69% below its historical high of $15.63B set on June 30, 2021
3-Year Low Comparison: AZN quarterly cash & cash equivalents is at its 3-year low
Sector Comparison: AZN quarterly cash & cash equivalents is higher than 97.69% of companies in Healthcare sector

Performance

AZN Performance
Metric	Date	Value	3M	1Y	3Y	5Y
Quarterly Cash & Cash Equivalents	Jun 30, 26	$4.89B	-36.3%	-31.2%	-15.8%	-68.7%
Annual Cash & Cash Equivalents	Dec 31, 25	$5.74B	–	+1.5%	-10.4%	-28.2%
Price	Aug 20, 26	$164.49	-13.3%	+104.4%	+138.8%	+177.0%
Quarterly Current Assets	Jun 30, 26	$27.97B	-5.6%	-3.4%	+22.4%	+2.5%
Quarterly Total Liabilities	Jun 30, 26	$65.46B	-1.8%	-3.2%	+10.7%	+13.0%
Quarterly Working Capital	Jun 30, 26	-$3.59B	-21.3%	+21.9%	-1.5%	-171.0%
Quarterly Net Income	Jun 30, 26	$2.51B	-18.5%	+1.2%	+37.8%	+355.8%

Quarterly Cash & Cash Equivalents Highs

AZN Quarterly Cash & Cash Equivalents Highs Comparison
Period	High	Date	Current
1Y	$8.18B	Sep 30, 25	-40.2%
3Y	$8.18B	Sep 30, 25	-40.2%
5Y	$15.63B	N/A	-68.7%
All	$15.63B	Jun 30, 21	-68.7%

Quarterly Cash & Cash Equivalents Lows

AZN Quarterly Cash & Cash Equivalents Lows Comparison
Period	Low	Date	Current
1Y	$4.89B	Jun 30, 26	at low
3Y	$4.89B	Jun 30, 26	at low
5Y	$4.89B	Jun 30, 22	+0.1%
All	$0.00	Mar 31, 00	N/A

Quarterly Cash & Cash Equivalents History

Month	Value	Change
Jun 2026	$4.89B	-36.2%
Mar 2026	$7.68B	+33.7%
Dec 2025	$5.74B	-29.8%
Sep 2025	$8.18B	+15.1%
Jun 2025	$7.11B	+31.8%
Mar 2025	$5.40B	-4.6%
Dec 2024	$5.65B	+14.7%
Sep 2024	$4.93B	-30.3%
Jun 2024	$7.08B	-11.8%
Mar 2024	$8.02B	+34.5%
Dec 2023	$5.96B	+16.6%
Sep 2023	$5.12B	-12.0%
Jun 2023	$5.81B	-10.1%
Mar 2023	$6.46B	+0.9%
Dec 2022	$6.41B	+30.8%
Sep 2022	$4.90B	+0.2%
Jun 2022	$4.89B	-16.1%
Mar 2022	$5.82B	-9.0%
Dec 2021	$6.40B	-10.5%
Sep 2021	$7.15B	-54.3%
Jun 2021	$15.63B	+101.3%
Mar 2021	$7.77B	-2.8%
Dec 2020	$7.99B	-5.4%
Sep 2020	$8.45B	+38.1%
Jun 2020	$6.12B	+46.8%
Mar 2020	$4.17B	-33.0%
Dec 2019	$6.22B	+30.1%
Sep 2019	$4.78B	-23.5%
Jun 2019	$6.25B	+26.0%
Mar 2019	$4.96B	-12.7%
Dec 2018	$5.68B	+33.3%
Sep 2018	$4.26B	+11.9%
Jun 2018	$3.81B	-1.6%
Mar 2018	$3.87B	-15.5%
Dec 2017	$4.58B	-12.1%
Sep 2017	$5.21B	-16.8%
Jun 2017	$6.26B	+70.6%
Mar 2017	$3.67B	-38.1%
Dec 2016	$5.93B	+47.3%
Sep 2016	$4.03B	-13.5%
Jun 2016	$4.65B	+13.2%
Mar 2016	$4.11B	-40.1%
Dec 2015	$6.86B	+48.8%
Sep 2015	$4.61B	+1.3%
Jun 2015	$4.55B	+22.2%
Mar 2015	$3.72B	-48.1%
Dec 2014	$7.18B	+20.5%

Month	Value	Change
Sep 2014	$5.96B	+3.1%
Jun 2014	$5.78B	+11.9%
Mar 2014	$5.16B	-48.6%
Dec 2013	$10.05B	+20.5%
Sep 2013	$8.34B	-8.3%
Jun 2013	$9.10B	+13.3%
Mar 2013	$8.03B	-6.1%
Dec 2012	$8.56B	+25.5%
Sep 2012	$6.82B	-25.9%
Jun 2012	$9.20B	-8.0%
Mar 2012	$10.00B	-7.5%
Sep 2011	$10.81B	+5.0%
Jun 2011	$10.30B	-4.6%
Mar 2011	$10.79B	-6.8%
Sep 2010	$11.58B	+4.7%
Jun 2010	$11.05B	+17.6%
Mar 2010	$9.40B	+29.2%
Jun 2009	$7.27B	+60.7%
Mar 2009	$4.52B	+24.7%
Sep 2008	$3.63B	-19.5%
Jun 2008	$4.51B	+38.5%
Mar 2008	$3.26B	-54.1%
Jun 2006	$7.10B	+17.4%
Mar 2006	$6.05B	+6.9%
Sep 2005	$5.66B	-3.3%
Jun 2005	$5.85B	+20.3%
Mar 2005	$4.86B	+16.0%
Sep 2004	$4.19B	+3.2%
Jun 2004	$4.06B	-2.9%
Mar 2004	$4.18B	-2.4%
Sep 2003	$4.29B	+7.8%
Jun 2003	$3.97B	-5.6%
Jun 2001	$4.21B	+42.9%
Jun 2000	$2.95B	>+9,900.0%
Mar 2000	$0.00	-100.0%
Dec 1999	$429.00M	-88.7%
Sep 1999	$3.79B	+88.1%
Jun 1999	$2.02B	-35.8%
Dec 1998	$3.14B	+859.6%
Jun 1998	$327.00M	-34.7%
Dec 1997	$500.89M	+12.9%
Dec 1996	$443.54M	+76.1%
Dec 1995	$251.87M	-73.8%
Jun 1995	$961.50M	+12.2%
Dec 1994	$856.75M	-36.6%
Dec 1993	$1.35B	-

FAQ

What is the current quarterly cash & cash equivalents of AZN?: As of today, AZN quarterly cash & cash equivalents is $4.89B
What is AZN quarterly cash & cash equivalents most recent change?: AZN quarterly cash & cash equivalents was down -36.25% on June 30, 2026
What is 1-year change in AZN quarterly cash & cash equivalents?: AZN quarterly cash & cash equivalents is down -31.16% year-over-year
How far is AZN quarterly cash & cash equivalents from its all-time high?: AZN quarterly cash & cash equivalents is currently -68.69% below its historical high of $15.63B set on June 30, 2021
How does AZN quarterly cash & cash equivalents rank versus sector peers?: AZN quarterly cash & cash equivalents is higher than 97.69% of companies in Healthcare sector
When is AZN next earnings release?: The next earnings release for AZN is on October 30, 2026

Cash and Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

Data Sources & References

AZN Official Website www.astrazeneca.com
AZN Profile on Yahoo Finance finance.yahoo.com/quote/AZN
AZN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/azn